Clinical Trial Update: Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for evaluation of 611 in Chinese adults with moderate-to-severe atopic dermatitis (Phase 1/2) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• 611

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Dermatitis, Atopic | Phase 1, Phase 2 | Status: COMPLETED